This Article Figures Only Full Text Full Text (PDF) Correspondence: Submit a response Alert me when this article is cited Alert me when Correspondence are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Monici, M.C. Articles by Vita, G. Search for Related Content PubMed PubMed Citation Articles by Monici, M.C. Articles by Vita, G. Related Collections All Neuromuscular Disease Muscle disease

Neurology 2003;60:993-997
© 2003 American Academy of Neurology

Activation of nuclear factor-B in inflammatory myopathies and Duchenne muscular dystrophy

M.C. Monici, MD, M. Aguennouz, PhD, A. Mazzeo, MD, C. Messina, MD and G. Vita, MD

From the Department of Neurosciences, Psychiatry, and Anaesthesiology, University of Messina, Italy.

Address correspondence and reprint requests to Prof. Giuseppe Vita, Clinica Neurologica 2, Policlinico Universitario, 98125 Messina, Italy; e-mail: giuseppe.vita{at}unime.it

Objective: To investigate the immunolocalization and activation of nuclear factor-B (NF-B) in polymyositis, dermatomyositis, and Duchenne muscular dystrophy (DMD).

Background: NF-B is a major transcription factor modulating the cellular immune, inflammatory, and proliferative responses. In skeletal muscle it was demonstrated to play a role in the expression of inducible genes in response to oxidative stress and ischemia/reperfusion injury, and also in myonuclear apoptosis and muscle catabolism. Some data suggest that NF-B may play a role in the pathogenesis of inclusion body myositis.

Methods: Muscle samples from five patients each with polymyositis, dermatomyositis, and DMD and 10 normal controls were studied by immunocytochemistry and Western blot of nuclear extracts for the activated form of NF-B. NF-B DNA binding activity was studied by electrophoretic mobility shift assay (EMSA).

Results: Immunoreactivity for NF-B was found in the cytoplasm of all regenerating fibers and in 20 to 40% of necrotic fibers. Western blot analysis of nuclear extracts showed a single band corresponding to 65 kd in all patients. EMSA analysis confirmed activation of NF-B pathway in inflammatory myopathies and, to a lesser extent, also in DMD.

Conclusions: These data indicate that nuclear factor-B pathway is activated in polymyositis, dermatomyositis, and Duchenne muscular dystrophy. It may play a role in modulating the immune response and in regulating myogenesis and muscle repair.

This article has been cited by other articles:

				M. Cucinotta, M. Visalli, M. Aguennouz, A. Valenti, S. Loddo, L. Altucci, and D. Teti Regulation of Interleukin-8 Gene at a Distinct Site of Its Promoter by CCAAT Enhancer-binding Protein Homologous Protein in Prostaglandin E2-treated Human T Cells J. Biol. Chem., October 31, 2008; 283(44): 29760 - 29769. [Abstract] [Full Text] [PDF]

				K. Hnia, J. Gayraud, G. Hugon, M. Ramonatxo, S. De La Porte, S. Matecki, and D. Mornet L-Arginine Decreases Inflammation and Modulates the Nuclear Factor-{kappa}B/Matrix Metalloproteinase Cascade in Mdx Muscle Fibers Am. J. Pathol., June 1, 2008; 172(6): 1509 - 1519. [Abstract] [Full Text] [PDF]

				N. P. Whitehead, C. Pham, O. L. Gervasio, and D. G. Allen N-Acetylcysteine ameliorates skeletal muscle pathophysiology in mdx mice J. Physiol., April 1, 2008; 586(7): 2003 - 2014. [Abstract] [Full Text] [PDF]

				N. Bakkar, J. Wang, K. J. Ladner, H. Wang, J. M. Dahlman, M. Carathers, S. Acharyya, M. A. Rudnicki, A. D. Hollenbach, and D. C. Guttridge IKK/NF-{kappa}B regulates skeletal myogenesis via a signaling switch to inhibit differentiation and promote mitochondrial biogenesis J. Cell Biol., February 25, 2008; 180(4): 787 - 802. [Abstract] [Full Text] [PDF]

				I. Eisenberg, A. Eran, I. Nishino, M. Moggio, C. Lamperti, A. A. Amato, H. G. Lidov, P. B. Kang, K. N. North, S. Mitrani-Rosenbaum, et al. Distinctive patterns of microRNA expression in primary muscular disorders PNAS, October 23, 2007; 104(43): 17016 - 17021. [Abstract] [Full Text] [PDF]

				K. Hnia, G. Hugon, F. Rivier, A. Masmoudi, J. Mercier, and D. Mornet Modulation of p38 Mitogen-Activated Protein Kinase Cascade and Metalloproteinase Activity in Diaphragm Muscle in Response to Free Radical Scavenger Administration in Dystrophin-Deficient Mdx Mice Am. J. Pathol., February 1, 2007; 170(2): 633 - 643. [Abstract] [Full Text] [PDF]

				I Strickland and S Ghosh Use of cell permeable NBD peptides for suppression of inflammation Ann Rheum Dis, November 1, 2006; 65(suppl_3): iii75 - iii82. [Abstract] [Full Text] [PDF]

				S. Messina, D. Altavilla, M. Aguennouz, P. Seminara, L. Minutoli, M. C. Monici, A. Bitto, A. Mazzeo, H. Marini, F. Squadrito, et al. Lipid Peroxidation Inhibition Blunts Nuclear Factor-{kappa}B Activation, Reduces Skeletal Muscle Degeneration, and Enhances Muscle Function in mdx Mice Am. J. Pathol., March 1, 2006; 168(3): 918 - 926. [Abstract] [Full Text] [PDF]

				Y. -W. Chen, K. Nagaraju, M. Bakay, O. McIntyre, R. Rawat, R. Shi, and E. P. Hoffman Early onset of inflammation and later involvement of TGF{beta} in Duchenne muscular dystrophy Neurology, September 27, 2005; 65(6): 826 - 834. [Abstract] [Full Text] [PDF]

				A. Mazzeo, M. Aguennouz, C. Messina, and G. Vita Immunolocalization and Activation of Transcription Factor Nuclear Factor {kappa}B in Dysimmune Neuropathies and Familial Amyloidotic Polyneuropathy Arch Neurol, July 1, 2004; 61(7): 1097 - 1102. [Abstract] [Full Text] [PDF]